亚特兰大 - 临床阶段生物制药公司Dogwood Therapeutics, Inc. (NASDAQ:DWTX)宣布,该公司现已符合纳斯达克的最低投标价格要求,有效解决了之前的上市合规问题。该公司直到最近还被称为Virios Therapeutics, Inc.,致力于开发治疗疼痛和疲劳相关疾病的药物。 这一公告与该公司正在进行的Pharmagesic (Holdings) Inc.整合同时发布 ...

T here are over 50 species of dogwood - part of the Cornus plant family - that are native to North America, Europe, Asia and ...

A kindergarten teacher at Dogwood Elementary School was surprised with a check for $1,000 and an award Monday afternoon.

A senseless act of vandalism of a memorial tree in a church yard in Duncan has a local man dumbfounded.

Therapeutics has regained compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market.

Top-line results from the Bateman Horne Center’s phase 2a study of IMC-2 for the treatment of Long-COVID are expected to be released in mid-November 2024. Integration efforts continue following the ...

Analyst Jason McCarthy of Maxim Group maintained a Buy rating on Dogwood Therapeutics (DWTX – Research Report), retaining the price ...

A house located at 44 Dogwood Lane in Cleona has a new owner. The 850-square-foot property, built in 1986, was sold on Oct.

A 2,868-square-foot house built in 1980 has changed hands. The spacious property located at 741 Dogwood Terrace in Boiling ...

Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the "Company"), formerly Virios Therapeutics, Inc., a clinical-stage biopharmaceutical company, announced today that ...

Kudos to Dogwood Festival board chair Andrew Porter, long-term senior volunteer Jackie Tuckey, and the many residents and volunteers trying to save and preserve the Fayetteville Dogwood Festival for ...

Houston White, the dynamic North Minneapolis entrepreneur, is creating a new blueprint for building wealth and community.